Chris Winrow

Chris Winrow

Company: Cyclerion

Job title: Vice President & Head of Translational Medicine


Panel Discussion: Integrating Biomarkers Throughout the Trajectory of CNS Drug Discovery & Development to Guide Clinical Decisions 12:00 pm

Discussing & debating whether biopharma should strive to achieve disease modification or improvement in quality of life when developing therapies for Alzheimer’s Exploring the impact of Aducanumab on international approval for neurodegenerative disease Learning what steps you must take to tailor your drug development approach to meet regulatory standardsRead more

day: Day 2 afternoon

From Concept to Clinic: Targeting the Nitric Oxide-Soluble Guanylate Cyclase-cGMP Pathway for Neurodegenerative Diseases 2:30 pm

Unlocking the full therapeutic potential of the nitric oxide-soluble guanylate cyclase-cGMP signaling pathway in the brain Demonstrating successful clinical translation of sGC stimulation for CNS drug development Exploring the benefits of incorporating objective biomarkers in early clinical developmentRead more

day: Track B - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.